Designer drugs and sexual dysfunction. [PDF]
Benyó M.
europepmc +2 more sources
Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing. [PDF]
Fleury Curado T +17 more
europepmc +2 more sources
Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs. [PDF]
Burnett CJ, Krashes MJ.
europepmc +3 more sources
High-Speed Identification of Designer Drugs by Multiple Mass Spectrometry
Stephan Kölliker, Michael Oehme
doaj +3 more sources
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB<sub>2</sub> Agonists with Neuroprotective Effects. [PDF]
Gioé-Gallo C +24 more
europepmc +2 more sources
Occurrence of Takotsubo Cardiomyopathy after Synthetic Cannabinoid Consumption [PDF]
Background: Synthetic cannabinoid use such as “K2” and “Spice” is popular secondary to its inability to be detected in a urine drug screen. It is associated with a wide range of myocardial pathologies including obstructive and non-obstructive coronary ...
Denelle Mohammed
doaj +1 more source
The DREADDful Hurdles and Opportunities of the Chronic Chemogenetic Toolbox
The chronic character of chemogenetics has been put forward as one of the assets of the technique, particularly in comparison to optogenetics. Yet, the vast majority of chemogenetic studies have focused on acute applications, while repeated, long-term ...
Marie Claes, Lies De Groef, Lieve Moons
doaj +1 more source
Oneiroid catatonia due to the usage of spice: The case study
Introduction Designer drugs, as a term, first came about in the 1980s. Most of these “designer drugs” have synthetic cannabinoids and other psychoactive formulas difficulty to detect. Objectives A 28 year man was referred to the hospital.
O. Pityk +4 more
doaj +1 more source
Recent advancements in chemogenetic tools, such as designer receptors exclusively activated by designer drugs (DREADDs), allow the simultaneous manipulation of activity over a specific, broad brain region in nonhuman primates.
Kei Oyama +2 more
doaj +1 more source
Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible. [PDF]
To uncover the circuit-level alterations that underlie atypical sensory processing associated with autism, we adopted a symptom-to-circuit approach in the Fmr1-knockout (Fmr1-/-) mouse model of Fragile X syndrome.
A Contractor +53 more
core +2 more sources

